Biotech

All Articles

Novo inks $600M NanoVation offer to analyze genetic drugs ex-liver

.Novo Nordisk is actually continuing its push in to hereditary medicines, accepting to compensate Na...

Innovent links cytokine to intestines cancer cells actions

.Innovent Biologics has made the scenario that its checkpoint inhibitor-cytokine fusion protein has ...

Merck, Daiichi ADC strikes goal in period 3 lung cancer cells research study

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina strengthens artificial intelligence focus with collab to choose cancer cells aim ats

.Five months after Rakovina Therapies turned towards artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medication hits in phase 3, intimidates BioMarin

.Ascendis Pharma has become a potential danger to BioMarin's Voxzogo, stating period 3 development c...

Despite ph. 3 skip, Alkeus views pathway ahead of time for eye health condition property

.Though Alkeus Pharmaceuticals' dental eye ailment property neglected to substantially reduce geogra...

Kairos goes social along with $6M IPO to cash tests of cancer medication

.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss...

Vaccine as well as Keytruda combination efficient in squamous tissue carcinoma

.Invulnerable checkpoint inhibitors are the superheroes of cancer therapy. Medicines like Bristol My...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...

Regeneron's Opdualag competitor presents 57% reaction cost

.Regeneron is back with long-term consequence for its own LAG-3 prevention as well as PD-1 inhibitor...